Molecular studies have nominated several genes as potential drivers involved in sporadic ACC tumorigenesis, including insulin-like growth factor 2 (IGF2) [12,13], β-catenin (CTNNB1) [14], and TP53 [15], among others. Here, CTNNB1 is linked to adrenal cortex carcinoma.